ONO-1162 Phase II Study A placebo-controlled multicenter double-blind randomized parallel-group study in patients with chronic heart failure

Trial Profile

ONO-1162 Phase II Study A placebo-controlled multicenter double-blind randomized parallel-group study in patients with chronic heart failure

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2016

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 28 Jan 2016 New trial record
    • 14 Jan 2016 Primary endpoint of reduction in resting HR from baseline at the 6-week treatment has been met according to results published in the Circulation Journal.
    • 14 Jan 2016 Results published in the Circulation Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top